Topics: Performance Enhancing Drugs
Open Outcry for the Past
November 24, 2014
John Neal of PTI Securities & Futures previews the week’s markets. Chris Manns and Bruce Moran are in-studio talking financial systems, the Middle East and more. Charlie Carey, board of directors at the CME Group talks high-frequency trading, the demise of open outcry markets and more. Finally, David Andalman of DACS Research talks technicals.
Right to Work
November 20, 2014
Brendan Cournane is in-studio talking markets, stagnant wages and more. Kevin O’Neill discusses age restrictions in professional sports. Then Alan Mather, Principal of Lindblom High School on Chicago’s southside, discusses the challenges his school faces in West Englewood and how they’re overcoming them.
Saving Face
November 19, 2014
Lou Michels is in-studio discussing the Keystone Pipeline, Adrian Peterson ruling and DEA raids in NFL locker rooms. David Andalman of PTI Securities & Futures previews the day’s trading session.
Japanese Recession
November 17, 2014
John Neal of PTI Securities & Futures previews the week’s trading session and covers the Halliburton and Baker Hughes merger. Chris Manns is in-studio talking commodity markets and Ukraine with Olga Halaburda of Ukraine Power Videos, Inc.. Finally, David Andalman of DACS Research provides technical analysis on today’s market trends.
If You’re Not Cheating, You’re Not Trying
August 26, 2014
Brendan Cournane is in-studio talking Pete Rose, cheating in sports and the situation with ISIS. Joel Elconin of Benzinga talks pre-market news.